Microba Life Sciences Limited (ASX:MAP)

Microba Life Sciences Revenue

Microba Life Sciences had revenue of 7.32M AUD in the half year ending December 31, 2025, with 123.66% growth. This brings the company's revenue in the last twelve months to 14.90M, down -11.81% year-over-year. In the fiscal year ending June 30, 2025, Microba Life Sciences had annual revenue of 15.67M with 29.60% growth.

• Revenue (ttm): 14.90M
• Revenue Growth: -11.81%
• P/S Ratio: 3.27
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 48.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	15.67M	3.58M	29.60%
Jun 30, 2024	12.09M	6.67M	123.06%
Jun 30, 2023	5.42M	731.49K	15.60%
Jun 30, 2022	4.69M	956.20K	25.62%
Jun 30, 2021	3.73M	823.42K	28.31%